These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Miglioli M; Barbara L Gut; 1991 Aug; 32(8):929-31. PubMed ID: 1885075 [TBL] [Abstract][Full Text] [Related]
6. 5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada. Sutherland LR; Martin F Dig Dis Sci; 1987 Dec; 32(12 Suppl):64S-66S. PubMed ID: 3319459 [TBL] [Abstract][Full Text] [Related]
7. Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis. Mulder CJ; Fockens P; Meijer JW; van der Heide H; Wiltink EH; Tytgat GN Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):549-53. PubMed ID: 8823568 [TBL] [Abstract][Full Text] [Related]
8. 5-ASA enemas for refractory distal ulcerative colitis. An open trial. Kandel G; Prokipchuk EJ J Clin Gastroenterol; 1987 Oct; 9(5):536-40. PubMed ID: 3680902 [TBL] [Abstract][Full Text] [Related]
11. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: a randomized, controlled trial. Friedman LS; Richter JM; Kirkham SE; DeMonaco HJ; May RJ Am J Gastroenterol; 1986 Jun; 81(6):412-8. PubMed ID: 3518408 [TBL] [Abstract][Full Text] [Related]
12. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Marshall JK; Irvine EJ Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961 [TBL] [Abstract][Full Text] [Related]
13. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Odze R; Antonioli D; Peppercorn M; Goldman H Am J Surg Pathol; 1993 Sep; 17(9):869-75. PubMed ID: 8352372 [TBL] [Abstract][Full Text] [Related]
14. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559 [TBL] [Abstract][Full Text] [Related]
15. Is topical therapy necessary in acute distal colitis? Double-blind comparison of high-dose oral mesalazine versus steroid enemas in the treatment of active distal ulcerative colitis. Cobden I; al-Mardini H; Zaitoun A; Record CO Aliment Pharmacol Ther; 1991 Oct; 5(5):513-22. PubMed ID: 1793782 [TBL] [Abstract][Full Text] [Related]
16. 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: long-term results. Guarino J; Chatzinoff M; Berk T; Friedman LS Am J Gastroenterol; 1987 Aug; 82(8):732-7. PubMed ID: 3496786 [TBL] [Abstract][Full Text] [Related]
17. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas. Barber GB; Lee DE; Antonioli DA; Peppercorn MA Am J Gastroenterol; 1985 Aug; 80(8):612-4. PubMed ID: 2862789 [TBL] [Abstract][Full Text] [Related]
18. Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial. Pullan RD; Ganesh S; Mani V; Morris J; Evans BK; Williams GT; Rhodes J Gut; 1993 May; 34(5):676-9. PubMed ID: 8504970 [TBL] [Abstract][Full Text] [Related]